cellcentric
Manufacturing · Energy & Utilities
$340Mtotal raised · 2 rounds on record
$220Mlatest round · Series D · May 2026 · 6 mo ago
2021founded
15stories in the press
Overview
Cellcentric vereint 30 Jahre Expertise in der Brennstoffzellentechnologie, unterstützt von Daimler Truck AG und Volvo Group. Ziel: klimaneutrale Mobilität.
Funding and backers
Total raised
$340M
2 rounds on record
Latest round
$220M
Series D · May 2026 · 6 mo ago
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 16
Recognition CellCentric wins Business of the Year at 36th Business Weekly Awards ahead of tipped US IPO Cambridge Network · cambridgenetwork.co.uk
May 6
Raised a round Series D $220M · pharmaphorum
May 20, 2025
Raised a round Venture round $120M · Pulse 2.0
Apr 2, 2025
Expanded British biotech CellCentric expands to Boston with plans to grow into late-stage clinical development · fiercebiotech.com
2021
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series D | May 2026 | $220M | — | pharmaphorum |
| Venture round | May 2025 | $120M | — | Pulse 2.0 |
Registers and programsofficial lists and records that name the company
| Legal entity | Co. KG | its site |
Founders and leadersfrom filings, registers and the company's site
Lars LjungströmGeschäftsführungcompany's site
Nicholas LoughlanGeschäftsführungcompany's site
Kai Wörner PersönlichGeschäftsführungcompany's site
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
About Dynelectro The Team Behind Industrial SOEC From world-leading researchers and experienced engineers to commercial leaders, board…
Electric Hydrogen is a United States company that designs and manufactures large electrolyzer systems for producing green hydrogen from…
Fourier is a hydrogen technology company developing highly modular and automated electrolyzers that make on-site hydrogen widely…
HTM Hydro Technology Motors is a German hydrogen and energy technology company that develops drive systems for sustainable hydrogen…
Reliable FPS combustion, safety, controls and measurement systems are trusted worldwide in the power generation, pulp and paper and…
We’re leading a clean industrial revolution by decarbonizing hard-to-abate industries. Steel is just the beginning.
People
Lars Ljungström
Geschäftsführung
Nicholas Loughlan
Geschäftsführung
Kai Wörner Persönlich
Geschäftsführung
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
Cellcentric's next fuel cell is readying for production, but hydrogen infrastructure must catch up
Read more
Report
CellCentric wins Business of the Year at 36th Business Weekly Awards ahead of tipped US IPO Cambridge Network
Tony Quested writes: CEO Will West winged in from New York as his company CellCentric won the 36th annual Business Weekly Awards' coveted Business of the Year crown at Queens' College.
Read more
Report
Toyota Takes A Third Of cellcentric: What The Fuel Cell Truck Deal Really Buys
On July 27, Volvo Group, Daimler Truck AG, cellcentric and Toyota signed a binding agreement making Toyota an equal one-third owner of cellcentric alongside the two European truck groups that founded it. Closing is expected around the end of 2026 or the s
Read more
Report
CellCentric: $220 Million Series D Raised To Advance Inobrodib Trials For Multiple Myeloma
CellCentric announced the completion of an oversubscribed $220 million Series D financing to support pivotal clinical trials of inobrodib, the company's first-in-class oral p300/CBP inhibitor for the treatment of multiple myeloma.
Read more
Report
CellCentric raises $220M for a 'transformative' multiple myeloma medicine
A Series D round led by Venrock will support an ongoing Phase 2 study, and planned Phase 3 trial, of an oral drug the biotech sees as a differentiated option for patients with persistent disease.
Read more
Report
CellCentric pockets $220m for blood cancer programme
CellCentric has raised $220 million in a Series D financing that will help fund pivotal trials of p300/CBP inhibitor inobrodib in multiple myeloma.
Read more
Report
Toyota's Entry Into Cellcentric Signals Push to Accelerate Hydrogen Truck Adoption
By joining Daimler Truck and Volvo, Toyota brings fuel cell expertise to a joint effort aimed at making hydrogen viable for heavy-duty transport.
Read more
Report
Toyota Motor Corporation aims to join Volvo Group and Daimler Truck as equal shareholder in the fuel cell joint venture cellcentric
Volvo Group, Daimler Truck, cellcentric and Toyota Motor Corporation signed a non-binding Memorandum of Understanding to collaborate on fuel cell technology....
Read more
Report
Show more news